Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework

N. E. MacDonald; E. Dube; J. L. Comeau

doi:10.1016/j.vaccine.2022.05.052

Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework

N. E. MacDonald, E. Dube, J. L. Comeau

Résultat de recherche: Comment/debate › examen par les pairs

Langue d'origine	English
Pages (de-à)	3927-3930
Nombre de pages	4
Journal	Vaccine
Volume	40
Numéro de publication	29
DOI	https://doi.org/10.1016/j.vaccine.2022.05.052
Statut de publication	Published - juin 23 2022
Publié à l'externe	Oui

ASJC Scopus Subject Areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

PubMed: MeSH publication types

Journal Article

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/j.vaccine.2022.05.052

Autres fichiers et liens

Citer

@article{b6c7d75ad9e24c4895400e6a9c2aec51,

title = "Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework",

author = "MacDonald, {N. E.} and E. Dube and Comeau, {J. L.}",

year = "2022",

month = jun,

day = "23",

doi = "10.1016/j.vaccine.2022.05.052",

language = "English",

volume = "40",

pages = "3927--3930",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "29",

}

TY - JOUR

T1 - Have vaccine hesitancy models oversimplified a complex problem to our detriment? The Adapted Royal Society of Canada vaccine uptake framework

AU - MacDonald, N. E.

AU - Dube, E.

AU - Comeau, J. L.

PY - 2022/6/23

Y1 - 2022/6/23

UR - http://www.scopus.com/inward/record.url?scp=85131092246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131092246&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2022.05.052

DO - 10.1016/j.vaccine.2022.05.052

M3 - Comment/debate

C2 - 35637069

AN - SCOPUS:85131092246

SN - 0264-410X

VL - 40

SP - 3927

EP - 3930

JO - Vaccine

JF - Vaccine

IS - 29

ER -